tiprankstipranks
Ligand Pharma (LGND)
NASDAQ:LGND

Ligand Pharma (LGND) Technical Analysis

776 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Ligand Pharma’s (LGND) Moving Averages Convergence Divergence (MACD) indicator is 0.16, suggesting Ligand Pharma is a Sell.
Ligand Pharma’s (LGND) 20-Day exponential moving average is 81.53, while Ligand Pharma’s (LGND) share price is $84.79, making it a Buy.
Ligand Pharma’s (LGND) 50-Day exponential moving average is 80.41, while Ligand Pharma’s (LGND) share price is $84.79, making it a Buy.

Ligand Pharma (LGND) Pivot Points

Jul 02, 2024, 11:45 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
80.17
81.01
82.64
83.48
85.11
85.95
87.58
Fibonacci
81.01
81.96
82.54
83.48
84.43
85.01
85.95
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ligand Pharma (LGND) Moving Averages

Jul 02, 2024, 11:45 PM
Period
Simple
Exponential
MA5
81.63Buy
82.62Buy
MA10
80.85Buy
81.69Buy
MA20
81.29Buy
81.53Buy
MA50
80.10Buy
80.41Buy
MA100
77.66Buy
77.74Buy
MA200
70.22Buy
72.26Buy
Ligand Pharma’s (LGND) 10-Day exponential moving average is 81.69, while Ligand Pharma’s (LGND) share price is $84.79, making it a Buy.
Ligand Pharma’s (LGND) 100-Day exponential moving average is 77.74, while Ligand Pharma’s (LGND) share price is $84.79, making it a Buy.
Ligand Pharma’s (LGND) stock price is $84.79 and Ligand Pharma’s (LGND) 50-day simple moving average is 80.10, creating a Buy signal.
Ligand Pharma’s (LGND) stock price is $84.79 and Ligand Pharma’s (LGND) 100-day simple moving average is 77.66, creating a Buy signal.
Ligand Pharma’s (LGND) stock price is $84.79 and Ligand Pharma’s (LGND) 200-day simple moving average is 70.22, creating a Buy signal.

Ligand Pharma (LGND) Technical Indicators

Jul 02, 2024, 11:45 PM
Name
Value
Implied Action
RSI (14)
59.38
Neutral
STOCH (9,6)
92.69
Sell
STOCHRSI (14)
92.77
Sell
MACD (12,26)
0.16
Sell
ADX (14)
22.47
Neutral
Williams %R
-10.60
Sell
CCI (14)
140.32
Sell
ATR (14)
2.72
-
Ultimate Oscillator
59.78
Neutral
ROC
6.69
Buy
Ligand Pharma’s (LGND) Relative Strength Index (RSI) is 59.38, creating a Neutral signal.
Ligand Pharma’s (LGND) Trend Strength Indicator (ADX) is 22.47, creating a Neutral signal.
Ligand Pharma’s (LGND) Commodity Channel Index (CCI) is 140.32, creating a Sell signal.
Ligand Pharma’s (LGND) Price Rate of Change (ROC) is 6.69, creating a Buy signal.

FAQ

Is LGND a Buy, Hold, or Sell?
Based on LGND’s technical indicators, LGND is a Buy.
    What is LGND’s RSI (14)?
    LGND’s RSI (14) is 59.38, which suggests LGND is a Neutral.
      What is LGND’s MACD?
      LGND’s MACD is 0.16, which suggests LGND is a Sell.
        What is LGND’s 5-day moving average?
        LGND’s 5-day moving average is 81.63, which suggests LGND is a Buy.
          What is LGND’s 20-day moving average?
          LGND 20-day moving average is 81.29, which suggests LGND is a Buy.
            What is LGND’s 50-day moving average?
            LGND’s 50-day moving average is 80.10, which suggests LGND is a Buy.
              What is LGND’s 200-day moving average?
              LGND’s 200-day moving average is 70.22, which suggests LGND is a Buy.
                What is LGND’s Williams % R (14)?
                LGND’s Williams % R (14) is -10.60, which suggests LGND is a Sell.
                  What is LGND’s CCI (14)?
                  LGND’s CCI (14) is 140.32, which suggests LGND is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis